» Authors » Graham R Ball

Graham R Ball

Explore the profile of Graham R Ball including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 739
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ajonu C, Grundy R, Ball G, Zafeiris D
Funct Integr Genomics . 2025 Jan; 25(1):8. PMID: 39762615
Gene‒gene interactions play pivotal roles in disease pathogenesis and are fundamental in the development of targeted therapeutics, particularly through the elucidation of oncogenic gene drivers in cancer. The systematic analysis...
2.
Kurozumi S, Ball G
Int J Clin Oncol . 2024 Aug; 29(11):1669-1675. PMID: 39181953
Cancer is highly diverse and heterogeneous. Accurate and rapid analysis of the characteristics of individual cancer cells, using a complex array of big data that includes various clinicopathological features and...
3.
Szakmany T, Fitzgerald E, Garlant H, Whitehouse T, Molnar T, Shah S, et al.
Front Immunol . 2024 Feb; 14:1308530. PMID: 38332914
Introduction: Early diagnosis of sepsis and discrimination from SIRS is crucial for clinicians to provide appropriate care, management and treatment to critically ill patients. We describe identification of mRNA biomarkers...
4.
Aljohani A, Toss M, El-Sharawy K, Mirza S, Ball G, Green A, et al.
Am J Cancer Res . 2022 Mar; 12(2):469-489. PMID: 35261781
Lymphovascular invasion (LVI) is a key step in breast cancer (BC) metastasis. Targeting the molecular drivers of LVI can improve BC patients' management. However, the underlying molecular mechanisms of LVI...
5.
Abdel-Fatah T, Ball G, Thangavelu P, Reid L, McCart Reed A, Saunus J, et al.
JAMA Netw Open . 2020 Jul; 3(7):e209486. PMID: 32633764
Importance: There is no proven test that can guide the optimal treatment, either endocrine therapy or chemotherapy, for estrogen receptor-positive breast cancer. Objective: To investigate the associations of sperm-associated antigen...
6.
Al-Juboori S, Vadakekolathu J, Idri S, Wagner S, Zafeiris D, Pearson J, et al.
J Exp Clin Cancer Res . 2019 May; 38(1):210. PMID: 31118051
Background: Metformin, a biguanide, is one of the most commonly prescribed treatments for type 2 diabetes and has recently been recommended as a potential drug candidate for advanced cancer therapy....
7.
Wagner S, Vadakekolathu J, Tasian S, Altmann H, Bornhauser M, Pockley A, et al.
Blood Adv . 2019 Apr; 3(8):1330-1346. PMID: 31015209
Acute myeloid leukemia (AML) is a genetically heterogeneous hematological malignancy with variable responses to chemotherapy. Although recurring cytogenetic abnormalities and gene mutations are important predictors of outcome, 50% to 70%...
8.
Thompson A, Clements K, Cheung S, Pinder S, Lawrence G, Sawyer E, et al.
Eur J Cancer . 2018 Aug; 101:210-219. PMID: 30092498
Background: Management of screen-detected ductal carcinoma in situ (DCIS) remains controversial. Methods: A prospective cohort of patients with DCIS diagnosed through the UK National Health Service Breast Screening Programme (1st...
9.
Abdel-Fatah T, Rees R, Pockley A, Moseley P, Ball G, Chan S, et al.
Oncotarget . 2018 Jan; 8(68):112245-112257. PMID: 29348822
Cancer biomarkers that can define disease status and provide a prognostic insight are essential for the effective management of patients with breast cancer (BC). The prevalence, clinicopathological and prognostic significance...
10.
Steele K, Macmillan R, Ball G, Akerlund M, McCulley S
J Plast Reconstr Aesthet Surg . 2017 Dec; 71(2):185-193. PMID: 29203259
Background: Timing of autologous breast reconstruction in patients requiring adjuvant radiotherapy remains contentious. The primary objective of this study was to assess clinical and patient reported outcomes in immediate reconstruction...